ECMM Candida Registry - CandiReg — CandiReg  

Invasive Candidiases Clinical Trial

Official title: ECMM Candida Registry - CandiReg

Status Recruiting

Clinical Trial Summary

The objective of the European Confederation of Medical Mycology - ECMM Candida Registry (CandiReg) is to overcome the lack of knowledge on epidemiology, clinical course, and molecular characteristics of invasive infections due to invasive Candida infections and to function as a platform for future studies and in case of outbreaks.

Clinical Trial Description

The specific objectives are:

To describe the global incidence of invasive Candida infection To monitor trends globally and locally over time To define patient risk groups To assess antifungal resistance among Candida spp. causing invasive diseases worldwide To assess attributable mortality of invasive Candida infection To assess incremental costs associated with invasive Candida infection

To describe the clinical pattern of disease To document diagnostic procedures performed for confirmation of diagnosis To describe first-line and salvage treatment regimens applied, guideline adherence, their efficacy and impact on patient survival To inform consensus guidelines To develop clinical screening and diagnostic procedures

Set up of a collection of isolates with molecular characterization and evaluation of resistance genes ;

Related Conditions & MeSH terms

• Candidiasis
• Candidiasis, Invasive
• Invasive Candidiases

• NCT number: NCT03450005
• Study type: Observational
• Source: University of Cologne
• Contact: Oliver Cornely, MD
• Phone: +49 221 478
• Email: oliver.cornely@uk-koeln.de
• Status: Recruiting
• Start date: January 18, 2018
• Completion date: December 31, 2026